AI develops antibodies:
In its search for new antibody treatments to combat serious diseases, Boehringer Ingelheim relies on the support of AI.
cio.de/a/ki-entwickelt-antikoerper,3731028
Story Details
| Last Updated | |
| Total Articles | 2 |
Main Topics
field that develops and studies software enabling machines to exhibit intelligent behavior
Similar to This
Previous
yicaiglobal.com Nov 05
Sino Biopharm Soars After Striking Over USD7 Billion Cancer Drug Deal With Boehringer Ingelheim
yicaiglobal.com/news/sino-biopharm-surges-after-striking-over-usd7-billion-cancer-drug-deal-with-boehringer-ingelheim
Pharmaceutical industry paid 15 million Swiss francs to university hospitals in 2025
bilanz.ch/unternehmen/universitaeten-und-personal-erhalten-millionen-von-pharmaindustrie/f7g1r44
Boehringer launches major AI collaboration with Microsoft for new medications: The future of drug development lies in AI-based digital patient twins ...
echo-online.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/boehringer-startet-mit-microsoft-grosse-ki-arznei-kooperation-6577403
Paid articlePaywall Boehringer raises the alarm: Supply of new cancer drugs in danger: Pharmaceutical company executives predict in a dramatic open letter: Patients in Europe will ...
echo-online.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/boehringer-versorgung-mit-neuen-krebsmedikamenten-in-gefahr-6481972
How Boehringer Ingelheim turns bold ideas into scalable innovation: With its exploratory digital lab BI X, Boehringer Ingelheim consciously sets itself apart ...
computerwoche.de/article/4215338/wie-boehringer-ingelheim-aus-kuhnen-ideen-skalierbare-innovation-macht.html
Paid articlePaywall Antibiotic-resistant bacteria: Boehringer fights the “silent pandemic”: Millions of people die every year from antibiotic-resistant germs. Why the pharmaceutical ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/resistente-keime-boehringer-kaempft-gegen-stille-pandemie-6273081
Paid articlePaywall Weight loss drugs: Boehringer attacks market leader Lilly: Lilly and Novo Nordisk dominate the field of obesity drugs. Boehringer is ramping up its efforts: One ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/abnehmmedikamente-boehringer-greift-marktfuehrer-lilly-an-5987592
Paid articlePaywall Investment crash: This is what the pharmaceutical company Boehringer has planned for its Ingelheim headquarters.
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/ingelheim-boehringer-investitionsschock-900-millionen-euro-investment-ausland-5877775
Key FactsBoehringer Ingelheim Shifts Focus to Global Expansion
Jul 15, 2026 · Reading time: ~45 sec.
Summary created with AI assistance · Source: schwaebische.de
Summary created with AI assistance · Source: schwaebische.de
- Boehringer Ingelheim’s currency-adjusted revenue increased to €15.8 billion in the first half of 2026, driven largely by growth in human pharmaceuticals.
- The drug Jardiance generated €5.7 billion in sales, while the animal health segment contributed €2.6 billion.
- Future investments will prioritize international growth markets due to unfavorable conditions in Germany.
- In June, planned investments of €900 million in Germany were suspended, including at the Biberach site employing about 8,000 people.
the industry is being de-prioritized— Médard Schoenmaeckers, Boehringer-Deutschland chief, criticized that in Germany the industry is being de-prioritized (in the context of health policy).
Boehringer Ingelheim: Pharmaceutical company halts investments in Germany: Chancellor Friedrich Merz wanted to get the German economy back on track. So far ...
t-online.de/finanzen/aktuelles/wirtschaft/id_101281826/boehringer-ingelheim-pharmakonzern-stoppt-die-investitionen-in-deutschland.html
Key FactsBoehringer Halts €900M Investments in Germany
Jun 4, 2026 · Reading time: ~45 sec.
Summary created with AI assistance · Source: t-online.de
Summary created with AI assistance · Source: t-online.de
- Boehringer Ingelheim cancels planned investments totaling €900 million at German sites scheduled between 2027 and 2030.
- The company attributes this move to geopolitical shifts and Germany’s upcoming health sector austerity measures involving increased mandatory rebates.
- Markets like the USA and China are becoming more attractive due to focused industrial policies, while Germany’s environment for pharma firms is deteriorating.
- This development reflects intensifying global competition and represents a setback for Chancellor Friedrich Merz’s economic growth agenda.
The next innovation, given the circumstances, is currently not heading to Germany— Médard Schoenmaeckers, Boehringer Ingelheim Germany CEO, according to Handelsblatt
Paid articlePaywall Boehringer Ingelheim: | "Groundbreaking" return to cancer therapy: After years of hardship, Boehringer Ingelheim has received approval for a new cancer drug ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/boehringer-schafft-bahnbrechende-rueckkehr-in-krebstherapie-4872983
How Boehringer Ingelheim uses IT in research: Researching new medications takes decades. With modern IT and AI, Boehringer Ingelheim is accelerating these ...
computerwoche.de/article/4020245/so-nutzt-boehringer-ingelheim-it-in-der-forschung.html
Boehringer Ingelheim and Sleip rely on AI for gait analysis in horses: Ingelheim (ots) - | - | Use of AI for easy diagnosis of lameness in horses - | ...
presseportal.de/pm/6631/5963621
AI in medium-sized companies: Boehringer Ingelheim - | faster to new drugs thanks to AI
handelsblatt.com/unternehmen/mittelstand/ki-im-mittelstand-boehringer-ingelheim-schneller-zum-neuen-medikament-dank-ki/100090885.html
This is how Boehringer Ingelheim is digitizing production: Digitization is a key success factor for Boehringer Ingelheim - | one component is the Digital Factory ...
cio.de/a/so-digitalisiert-boehringer-ingelheim-die-produktion,3698932
This is how Boehringer Ingelheim digitizes production: Digitalization is a key success factor for Boehringer Ingelheim - one component is the digital factory.
computerwoche.de/a/so-digitalisiert-boehringer-ingelheim-die-produktion,3698932
Quantum computing drives drug research forward: Markus Schümmelfeder, CIO at Boehringer Ingelheim, bets in the CIO Yearbook 2024 that we will see a quantum leap ...
cio.de/a/quantum-computing-treibt-die-arzneiforschung-voran,3721780
Boehringer Ingelheim centralizes data management: With a platform based on AWS, the pharmaceutical company wants to implement sophisticated data use cases from ...
cio.de/a/boehringer-ingelheim-zentralisiert-datenmanagement,3725903
Google's quantum computing division will help develop new drugs: Google’s Quantum AI division is teaming with pharmaceutical company Boehringer Ingelheim to ...
engadget.com/google-boehringer-ingelheim-quantum-computing-pharmaceutical-research-152855720.html
Next